期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血液病患儿侵袭性真菌感染39例联合治疗疗效分析 被引量：3

Combied antifungal treatment for invasive fungal infection in children with hematological diseases
原文传递
导出
摘要 目的探讨血液病患儿侵袭性真菌感染联合药物治疗组合及疗效。方法 2006年1月至2011年4月在中山大学孙逸仙纪念医院就诊的血液病合并侵袭性真菌感染并予以联合治疗患儿39例,对患儿的临床资料及治疗效果进行回顾性分析。结果联合抗真菌药物治疗者共48例次,其中拟诊11例次,临床诊断32例次,确诊5例次。两性霉素B联合卡泊芬净18次,无效3次;两性霉素B联合伊曲康唑静脉13次,口服4次,均有效;两性霉素B联合伏立康唑9次,无效1次;卡泊芬净联合伊曲康唑6次,无效1次;卡泊芬净联合伏立康唑5次,均有效;伊曲康唑联合制霉菌素1次,有效。完全缓解27例,部分缓解7例,放弃1例,恶化死亡4例。三唑类联合两性霉素B或卡泊芬净与两性霉素B联合卡泊芬净相比,效果差异无统计学意义(P>0.05)。结论 免疫功能明显抑制、既往侵袭性真菌感染且再次接受强化疗或造血干细胞移植、严重或突破性真菌感染、单药治疗失败或毒副反应大、合并移植物抗宿主病患儿的联合治疗疗效较满意。三唑类联合两性霉素B或卡泊芬净与两性霉素B联合卡泊芬净均可作为联合用药选择。 Objctive To evaluate the efficacies of treating invasive fungal infection （IFI） with double combinations in children with hematological diseases. Methods A retrospective clinical study was made on curative effect based on 39 patients from January 2006 to April 2011.Results A total of 48 IFIs were treated with combined antifungal therapy. Among them, 11 had possible diagnosis, 32 probable diagnosis and 5 proven diagnosis. Eighteen IFIs received amphotericin B combined with caspofungin, 3 invalid; 13 received amphotericin B and itraconazole injection, 4 oral solution, all effective; 9 received amphotericin B and voriconazole, 1 invalid; 6 received caspofungin and itraconazole, 1 invalid ; 5 received caspofungin and voriconazole, all effective. Totally 27 responded with complete remission, 8 partial remission, 1 abandoned, 4 dead. There was no significant difference among triazole combined with amphotericin B or caspofungin and amphotericin B with caspofungin （P〉O.05）.Conclusion Combined antifungal therapy shows impressive curing activity on patients with severe impaired immunological function, who receive strong chemotherapy, HSCT with past history of IFI, severe or breakthrough IFI, monotherapy failure or have intolerable side effects, and those having graft-versus- host disease after HSCT. Triazole combined with amphotericin B or caspofungin and amphotericin B with caspofungin are all choice.
作者 郭海霞 周敦华 黄科 黎阳 薛红漫 徐宏贵 鲁长明 陈纯 方建培
机构地区 中山大学孙逸仙纪念医院 儿科 皮肤科
出处 《中国实用儿科杂志》 CSCD 北大核心 2012年第8期599-603,共5页 Chinese Journal of Practical Pediatrics
关键词 血液病 侵袭性真菌感染 联合治疗 hematological disease invasive fungal infection combined therapy
分类号 R72 [医药卫生—儿科]
  • 相关文献

参考文献24

  • 1Maertens J, Theunissen K, Verhoef G, et al. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenie patients at high risk for invasive fungal infec- tion : a prospective feasibility study [J]. Clin Infect Dis, 2005, 41 (9) : 1242-1250.
  • 2Segal BH, Almyroudis NG, Battiwalla M, et al. Prevention and early treatment of invasive fungal infection in patients with can- cer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts[J]. Clin Infect Dis, 2007, 44(3):402-409.
  • 3Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cas- es from a prospective nationwide surveillance study [J].Clin In- feet Dis, 2004,39 (3) : 309-317.
  • 4中国侵袭性真菌感染工作组.血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(第一次修订)[J].中华内科杂志,2010,49(5):45l-一454.
  • 5Vallejo C, Rovira M. Prophylaxis and treatment of invasive fun- gal infection in neutropenic patients [J]. Rev Esp Quimioter, 2010,23(4) : 177-183.
  • 6沈志祥,陈秋生.血液病合并侵袭性真菌感染的临床特点与治疗[J].中华医学杂志,2005,85(21):1447-1448. 被引量：41
  • 7Wright JA, Bradfield SM, Park JR, et al. Prolonged survival after invasive aspergillosis: a single-institution review of 11 cases[J]. J Pediatr Hematol Oncol, 2003, 25(4) : 286-291.
  • 8Martino R, Lopez R, Sureda A, et al. Risk of reactivation of a recent invasive fungal infection in patients with hema- tological malignancies undergoing further intensive chemora- diotherapy: a single-center experience and review of the lit- erature[J]. Haematologica, 1997, 82(3) : 297-304.
  • 9Safdar A, Armstrong D. Infectious morbidity in critically ill pa- tients with cancer-J]. CAt Care Clin, 2001, 17(3): 531-570.
  • 10Manzoor NF, Azim S, Fadoo Z. Successful management of in- vasive aspergillosis with voriconazole and amphoteracin B ther- apy in a patient with acute mycloid leukemia (AML-M2) [J]. J Pak Med Assoc, 2010, 60(11 ) :977-979.

二级参考文献16

  • 1Caillot D, Mannone L, Cuisenier B, et al. Role of early diagnosis and aggressive surgery in the management of invasive pulmonary aspergillosis in neutropenic patients. Clin Microbiol Infect, 2001, 7:54-61.
  • 2Kami M, Kishi Y, Hamaki T, et al. The value of the chest computed tomography halo sign in the diagnosis of invasive pulmonary aspergillosis. An autopsy-based retrospective study of 48 patients. Mycoses, 2002, 45:287-294.
  • 3Mahfouz TH, Anaissie EJ. Prevention of fungal infections in the immunocompromised host. Curr Opin Invest Drugs, 2003, 4:974-990.
  • 4Winston DJ, Maziarz RT, Chandrasekar PH, et al. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial. Ann Intern Med, 2003, 138:705-713.
  • 5O'Brien SN, Blijlevens Nicole MA, Mahfouz TH, et al. Infections in patients with hematological cancer: recent developments. Hematology, 2003, 438-472.
  • 6Heussel CP, Kauczor HU, Heussel, et al. Early detection of pneumonia in febrile neutropenic patients: use of thin-section CT. AJR, 1997, 169: 1347-1353.
  • 7BICANIC T, HARRISON TS. Cryptococcal meningitis[J]. Br Med Bull, 2005, 72: 99-118.
  • 8HOPE WW, DENNING DW. Invaslve aspergillosis: eurrent and thture challenges in diagnosis and therapy[J]. Clin Microbiol Intect, 2004, 10(1): 2-4.
  • 9de BEULE K, van GESTEL J. Pharmacology of itraconazole[J].Drugs, 2001, 61 Suppl 1: 27-37.
  • 10van der HORST CM, SAAG MS, CLOUD GA, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome[J]. N Engl J Med, 1997, 337(1): 15-21.

共引文献51

同被引文献37

  • 1Robenshtok E, Gaffer-Gvili A, Goldberg E, et al. Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis [ J ]. J Clin Oncol, 2007, 25 (34): 5471-5489.
  • 2Schwartz S, Ruhnke M, Ribaud P, et al. Improved outcome in central nervous system aspergillosis, using voriconazole treat- ment[J]. Blood, 2005, 106(8): 2641-2645.
  • 3Upton A, Kirby KA, Carpenter P, et al. Invasive aspergillnsis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality [J]. Clin Infect Dis, 2007, 44(4): 531-540.
  • 4Crassard N, Hadden H, Piens MA, et al. Invasive aspergillosis in a paediatric haematology department: a 15-year review [J]. Mycoses, 2008, 51(2): 109-116.
  • 5Rojas R, Molina JR, Jarque I, et al. Outcome of Antifungal Combination Therapy for Invasive Mold Infections in Hematological Patients is Independent of the Chosen Combination [J]. Mediterr J Hematol Infect Dis, 2012, 4 (1): e2012011.
  • 6Bonnett CR, Cornish EJ, Harmsen AG, et al. Early neutrophil recruitment and aggregation in the murine lung inhibit germination of Aspergillus fumigatus Conidia [J]. Infect Immun, 2006, 74( 12 ): 6528-6539.
  • 7Afessa B, Peters SG. Major complications following hematopoi- etic stem cell transplantation [J]. Semin Respir Crit Care IVied, 2006, 27(3 ): 297-309.
  • 8Kotloff RM, Ahya VN, Crawford SW. Pulmonary complications of solid organ and hematopoietic stem cell transplantation [J]. Am J Respir Crit Care Med, 2004, 170 ( 1 ): 22-48.
  • 9Marr KA, Schlamm HT, Herbrecht R, et al. Combination antifunga therapy for inasi,e aspergllosis" a randomized trial [J]. Ann Intern Med, 2015, 162(2): 81-89.
  • 10Nosari A, Oreste P, Cairoli R, et al. Invasive aspergillosis in haematological malignancies: clinical findings arid management for intensive chemotherapy completion [J]. Am J Hematol,2001, 68(4): 231-236.

引证文献3

二级引证文献16

中国实用儿科杂志
2012年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部